Multiple Myeloma

Pre-Clinical Data Demonstrates Promising Potential of MannKind’s IRE1α Inhibitor to Treat Multiple Myeloma
Yahoo
Thu, 05/31/12 - 06:26 pm
MannKind
IRE1α inhibitor
MKC-3946
Multiple Myeloma
Biotech Hot Potato: Perifosine
Motley Fool
Wed, 05/9/12 - 09:01 am
perifosine
Aeterna Zentaris
Takeda
JNJ
Keryx
Multiple Myeloma
Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Pharmalive
Sat, 04/28/12 - 12:50 pm
ONYX Pharmaceuticals
Carfilzomib
Multiple Myeloma
AEterna, Keryx soar on study speculation
Marketwatch
Mon, 03/5/12 - 06:16 pm
Keryx
Aeterna Zentaris
perifosine
colorectal cancer
Multiple Myeloma
Onyx' Cancer Drug on Right Track
Yahoo/Zacks.com
Wed, 11/30/11 - 10:37 am
ONYX Pharmaceuticals
Carfilzomib
Multiple Myeloma
Onyx Pharma submits NDA for carfilzomib in relapsed and refractory multiple myeloma
Pharmabiz
Sun, 10/2/11 - 12:35 pm
ONYX Pharmaceuticals
Carfilzomib
proteasome inhibitors
Multiple Myeloma
Celgene's Revlimid Passes EU Safety Review
TheStreet.com
Fri, 09/23/11 - 12:03 pm
Celgene
Revlimid
Europe
EU
Multiple Myeloma
Revlimid side effects linked to protein in study
Reuters, UK
Tue, 08/9/11 - 10:10 am
Multiple Myeloma
Celgene
Revlimid
YM BioSciences JAK Inhibitor CYT387 Shown Active in Multiple Myeloma
Yahoo
Thu, 08/4/11 - 10:56 am
JAK inhibitors
CYT387
Multiple Myeloma
YM BioSciences
Celgene’s Blood-Cancer Treatment Backed by U.K. Cost Agency
Bloomberg
Tue, 07/26/11 - 09:57 pm
UK
Celgene
thalidomide
Multiple Myeloma
Ligand will start new study of multiple myeloma drug, plans to file for approval in mid-2013
Yahoo/AP
Wed, 06/22/11 - 10:22 pm
Ligand
Multiple Myeloma
melphalan
Keryx Biopharmaceuticals vs. AEterna Zentaris
Seeking Alpha
Thu, 06/9/11 - 10:17 am
Aeterna Zentaris
Keryx
perifosine
colorectal cancer
Multiple Myeloma
Celgene Stock Falls On Worries About Secondary Cancers
Forbes
Fri, 05/6/11 - 08:37 am
Celgene
cancer
Multiple Myeloma
Revlimid
Celgene Poised to Bounce Back After Revlimid Safety Blues
Seeking Alpha
Mon, 04/25/11 - 10:25 pm
Celgene
Revlimid
drug safety
Multiple Myeloma
Onyx multiple myeloma drug wins FDA fast-track status
Bizjournals.com
Tue, 02/1/11 - 08:20 am
ONYX Pharmaceuticals
Multiple Myeloma
FDA
fast track
Carfilzomib
Celgene: Revlimid Cancer Risk Knocks Stock
TheStreet.com
Mon, 12/6/10 - 11:04 am
Celgene
Revlimid
Multiple Myeloma
Onyx Delays Cancer Drug Application As FDA Asks for More Data
Motley Fool
Fri, 10/8/10 - 08:12 am
ONYX Pharmaceuticals
FDA
Carfilzomib
Multiple Myeloma
Celgene's Revlimid Marches on
Yahoo/Zacks
Sat, 08/21/10 - 01:35 pm
Celgene
Revlimid
Multiple Myeloma
Onyx's Next Blockbuster?
Forbes
Mon, 07/26/10 - 11:02 am
ONYX Pharmaceuticals
Carfilzomib
Multiple Myeloma
Celgene International Sarl Releases Results of Phase II Study on Multiple Myeloma Patients
Trading Markets
Sat, 06/12/10 - 10:14 am
Cellgene
Multiple Myeloma
dexamethasone
pomalidomide
lenalidomide

Pages